The Mechanistic Biology of Primary Immunodeficiency Disorders

计划入组 2,500 人 · 首次发布于 2018 年 1 月 9 日

Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders

首次发布于 1999 年 10 月 19 日

Diagnostic Immunization With Rabies Vaccine in Patients With PID

计划入组 40 人 · 首次发布于 2015 年 7 月 7 日

intravenous immunoglobulin (primary immunodeficiency disease)

GPR139 antagonists (CNS disorders/motor disorders)

Bleeding disorders (Gubra)

Institute For Neurodegenerative Disorders

United States

Ascendis Pharma Growth Disorders A/S

Denmark

Alzheimer's Disease And Related Disorders Association, Inc.

United States

Kedrion Biopharma Secures FDA Approval for QIVIGY, First Proprietary IVIG Therapy for Primary Immunodeficiency

FDA Approves ADMA Biologics' Innovative Yield Enhancement Process for Immune Globulin Production

CSL to Begin Clinical Trials for Horizon 2 Immunoglobulin Manufacturing Process Following FDA and EMA Discussions